Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › Billing code J9358

J9358

Injection, fam-trastuzumab deruxtecan-nxki, 1 mg

Medicaid paid $25.19M on code J9358 from 2018 through 2024, to 15 providers — the #1,377 code in the file by dollars. 30% of it was billed in Puerto Rico.

28Total paid$25.19M
24GClaims5,822
Paid per claim line$4K
33Providers billing it15
Box 32 · Location

Where J9358 is billed

  1. $7.7M
  2. $5.2M
  3. $4.0M
  4. $3.4M
  5. $3.3M
  6. $1.0M
  7. $212K
  8. $124K
  9. $65K
  10. $63K
  11. $56K
  12. $0

The largest of 12 states and territories, by the billing provider's address. States cover different services and set their own rates, so the same code can mean different things in different programs.

Ranked

Top providers billing J9358

#ProviderLocationClaimsPaid on J9358
1 Alivia Specialty, LLC Guaynabo, PR 715 $7.29M
2 City of Hope National Medical Center Duarte, CA 1,270 $4.84M
3 Arthur G James Cancer Hospital and Research Institute Columbus, OH 741 $4.00M
4 Dana-Farber Cancer Institute, INC. Boston, MA 1,252 $3.43M
5 Memorial Hospital for Cancer and Allied Diseases New York, NY 863 $3.32M
6 Yale New Haven Hospital New Haven, CT 540 $1.01M
7 Farmacia Doral, INC. San Juan, PR 39 $391K
8 Regents of the University of California San Diego, CA 124 $329K
9 HMH Hospitals Corporation Hackensack, NJ 32 $212K
10 Cancer & Hematology Centers of Western Mi, P.C. Grand Rapids, MI 19 $124K
11 County of Santa Clara San Jose, CA 41 $67K
12 Fred Hutchinson Cancer Center Seattle, WA 38 $65K
13 Honorhealth Phoenix, AZ 21 $63K
14 University of Miami Hospital and Clinics Miami, FL 76 $56K
15 Upmc Magee-Womens Hospital Pittsburgh, PA 51 $0.00